{
    "Trade/Device Name(s)": [
        "Prostate-63 Cancer Diagnostic Test",
        "Prostate-63 Prostate Cancer Diagnostic Test"
    ],
    "Submitter Information": "Asymmetrx, Inc.",
    "510(k) Number": "K050063",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NTR"
    ],
    "Summary Letter Date": "February 9, 2005",
    "Summary Letter Received Date": "January 12, 2005",
    "Submission Date": "December 28, 2004",
    "Regulation Number(s)": [
        "21CFR864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry"
    ],
    "Analyte Class(es)": [
        "anatomic pathology"
    ],
    "Analyte(s)": [
        "p63 protein"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed paraffin-embedded tissue"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunohistochemistry"
    ],
    "Methodologies": [
        "Immunohistochemistry"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Antibody"
    ],
    "Document Summary": "FDA 510(k) summary for Prostate-63 Cancer Diagnostic Test, a monoclonal antibody reagent for immunohistochemical detection of p63 protein in prostatic basal cells.",
    "Indications for Use Summary": "Aids in the differential diagnosis of prostate cancer by identifying p63 antigen in histological sections from formalin-fixed paraffin-embedded prostate tissue via immunohistochemistry.",
    "fda_folder": "Hematology"
}